Integrating Market Intelligence APIs into Your Pharmaceutical Launch Strategy

Why Real-Time Market Intelligence Matters in Pharma Launches

Launching a new drug feels like juggling eight flaming torches. One slip, and you risk wasted investment, missed patient needs and regulatory headaches. The good news? Real-time Market Intelligence can light your path.

• The global pharmaceutical market is projected to exceed $1.57 trillion by 2023 (Statista).
• Yet, 90% of drug launches fail to hit commercial targets.
• SMEs in Europe face tight budgets, strict regulations and intense competition.

Actionable Market Intelligence helps you:
– Spot emerging therapeutic trends.
– Calibrate pricing and distribution strategies.
– Anticipate competitor moves before they escalate.

In short: it turns guesswork into clarity.

Evaluating Nasdaq eVestment’s Market Intelligence API

Nasdaq’s eVestment Market Intelligence API is a powerful tool in the financial sector. It offers:

• Custom Power BI toolset: Pre-built dashboards, interactive visualisations and flexible data models.
• Market Analytics: Historical asset flows, risk profiles and growth potential.
• Calculations Explorer: Custom sets of products ranked by performance.
• Flows by Investor Domicile: Geographical risk and growth insights.
• Viewership Trends: Peer-group breakdowns and viewer activity metrics.

Strengths:
– Rapid setup with day-one custom dashboards.
– Deep historical datasets for asset managers.
– Interactive reports that work in Power BI.

Limitations for Pharmaceuticals:
– Generic focus on financial assets, not drug launches.
– Lacks predictive analytics specific to drug success metrics.
– Integration requires BI expertise and manual report building.
– No built-in regulatory or clinical trial data.
– Costs can escalate with multiple API keys and Power BI licensing.

Introducing Smart Launch by ConformanceX

Smart Launch is built exclusively for pharmaceutical SMEs. It integrates Market Intelligence APIs into a unified, AI-driven platform that guides you from pre-launch research to post-launch monitoring.

Key offerings:
– Predictive Analytics: Machine learning models forecast launch success, helping you adjust strategies in real time.
– Competitive Intelligence: Tailored data on rival drugs, pricing and regional approvals.
– Real-Time Market Intelligence: Seamless API feeds deliver the latest sales, prescribing and pipeline insights.
– Workflow Integration: Embed intelligence into your CRM, regulatory dossiers and sales planning tools.
– Continuous Improvement: Regular updates based on user feedback and emerging market trends.

USPs:
1. Integration of AI enables real-time data-driven insights.
2. Comprehensive predictive analytics minimise risks during launches.
3. Tailored competitive intelligence ensures you stay ahead of market trends.

Side-by-Side Comparison: Nasdaq vs Smart Launch

Let’s break it down:

1. Integration and Data Customisation

• Nasdaq eVestment: You get a Power BI toolset. Then you build and customise.
  • Strong for financial analysts.
  • Requires BI skills and separate licences.
• Smart Launch: Plug-and-play APIs.
  • Pre-configured dashboards focused on pharmaceuticals.
  • Integrates into existing launch workflows and regulatory hubs.

2. Predictive Analytics and Risk Assessment

• Nasdaq eVestment: Historical trend analysis for asset flows.
  • Good for spotting past patterns.
  • No built-in drug-launch forecasting.
• Smart Launch: AI models that predict commercial uptake, patient adherence and market penetration.
  • Actionable risk scores.
  • Early-warning alerts allow pivoting before launch.

3. Competitive Intelligence

• Nasdaq eVestment: Calculates asset strengths across broad markets.
  • Generic product benchmarking.
• Smart Launch: Deep dive into competitor drug profiles, pipeline status and regional approvals.
  • Tailored to molecular classes and therapeutic areas.
  • Regulatory milestone tracking.

4. Workflow and User Experience

• Nasdaq eVestment: Designed for data teams.
  • Steeper learning curve.
  • Manual report maintenance.
• Smart Launch: Intuitive interface for marketers, regulatory affairs and sales teams.
  • Role-based dashboards.
  • In-app guidance and automated alerts.

5. Support and Evolution

• Nasdaq eVestment: Standard enterprise support.
  • Updates align with financial market cycles.
• Smart Launch: Dedicated pharmaceutical success team.
  • Regular feature releases based on user feedback.
  • Localised insights for Europe, North America and emerging markets.

Implementation Tips for Pharma SMEs in Europe

1. Define your launch metrics:
   – Patient adoption rate.
   – Regional sales targets.
   – Reimbursement timelines.
2. Map your data sources:
   – Clinical trial registries.
   – Prescribing databases.
   – Competitor pipeline feeds.
3. Integrate APIs:
   – Use Smart Launch’s SDK for a quick setup.
   – Connect to your CRM and regulatory systems.
4. Train your team:
   – Host interactive workshops.
   – Leverage dashboards in daily stand-ups.
5. Monitor and iterate:
   – Review predictive scores weekly.
   – Adjust launch tactics based on alerts.

Conclusion

The pharmaceutical arena demands both speed and precision. While Nasdaq eVestment’s Market Intelligence API excels in financial analytics, it falls short when you need drug-specific foresight and seamless integration. Smart Launch by ConformanceX bridges that gap, delivering real-time Market Intelligence, predictive analytics and competitive insights tailored for your drug launch.

Ready to bring data-driven clarity to your next launch?
Explore how Smart Launch can transform your strategy.

Get a personalised demo ➔ https://www.conformancex.com/